
Conditions characterized by abnormally slow or shallow breathing during sleep, leading to elevated carbon dioxide and reduced oxygen levels.
Sleep-related hypoventilation syndromes are disorders in which breathing is insufficient to maintain normal oxygen and carbon dioxide levels during sleep. Unlike sleep apnea where breathing repeatedly stops, hypoventilation involves continuous but inadequate breathing. The result is a rise in blood carbon dioxide (hypercapnia) and fall in oxygen (hypoxemia) during sleep. Hypoventilation can occur due to obesity (obesity hypoventilation syndrome), lung disease, neuromuscular disorders, chest wall abnormalities, or brainstem dysfunction.
Obesity Hypoventilation Syndrome (OHS), the most common form, affects approximately 10-20% of obese patients with obstructive sleep apnea and up to 0.4% of the general adult population. The prevalence of all hypoventilation syndromes is increasing with rising obesity rates. Other forms are rarer and associated with specific underlying conditions.
Hypoventilation during sleep occurs when the respiratory system cannot maintain adequate gas exchange. In obesity hypoventilation syndrome, excess weight restricts chest wall movement and diaphragm function. Other causes include COPD and other lung diseases, neuromuscular diseases (muscular dystrophy, ALS, myasthenia gravis), chest wall disorders (kyphoscoliosis), brainstem lesions, congenital central hypoventilation syndrome (Ondine's curse), and medication effects (opioids, sedatives).
Defined by obesity (BMI ≥30), daytime hypercapnia (PaCO2 >45 mmHg), and sleep-disordered breathing, without other causes of hypoventilation. Often coexists with OSA.
Patients with chronic obstructive pulmonary disease may hypoventilate during sleep, particularly during REM sleep, leading to nocturnal hypoxemia.
Weakness of respiratory muscles leads to inability to maintain adequate ventilation, particularly during sleep when muscle tone naturally decreases.
A rare genetic disorder (Ondine's curse) where the automatic control of breathing is impaired, particularly during sleep.
Headaches upon waking are common due to elevated carbon dioxide levels during sleep causing cerebral vasodilation.
Poor sleep quality and nocturnal hypoxemia lead to significant daytime fatigue and sleepiness.
Dyspnea, particularly with exertion, may occur as the condition progresses and daytime gas exchange becomes affected.
Chronic hypoxemia and sleep disruption cause persistent fatigue and reduced exercise tolerance.
Swelling in the legs may occur as chronic hypoxemia leads to pulmonary hypertension and right heart strain (cor pulmonale).
Memory problems, difficulty concentrating, and confusion can result from chronic hypercapnia and sleep disruption.
Bluish discoloration of lips and fingertips may be visible due to low blood oxygen levels.
If you answer yes to any of these questions, consider consulting a sleep specialist:
Diagnosis requires demonstration of hypoventilation during sleep, typically showing elevated CO2 and reduced oxygen. Arterial blood gas analysis, overnight oximetry, and polysomnography with CO2 monitoring are key diagnostic tools.
Measurement of oxygen and carbon dioxide in arterial blood. Daytime hypercapnia (PaCO2 >45 mmHg) is required for diagnosis of obesity hypoventilation syndrome.
Sleep study that includes continuous monitoring of end-tidal or transcutaneous CO2 to document elevated carbon dioxide during sleep.
Continuous oxygen monitoring during sleep can show sustained desaturation patterns typical of hypoventilation (prolonged low oxygen rather than repetitive dips seen in OSA).
Spirometry and lung volume measurements help identify underlying lung disease or restrictive defects contributing to hypoventilation.
Elevated bicarbonate level suggests chronic CO2 retention as the body compensates for respiratory acidosis.
Treatment aims to normalize gas exchange during sleep and prevent complications. The approach depends on the underlying cause and severity of hypoventilation.
BiPAP with a backup rate or average volume-assured pressure support (AVAPS) provides ventilatory support during sleep, treating both obstructive events and hypoventilation.
For patients with OHS and concurrent OSA, CPAP alone may be sufficient if it normalizes daytime CO2. However, many patients require BiPAP.
May be needed in addition to ventilatory support, but oxygen alone without ventilation can worsen hypercapnia in some patients.
For OHS, weight loss (including bariatric surgery in appropriate candidates) can dramatically improve or resolve hypoventilation.
In severe cases unresponsive to noninvasive ventilation, tracheostomy with nocturnal ventilation may be necessary.
For congenital central hypoventilation syndrome and some neuromuscular conditions, phrenic nerve pacing can support breathing.
Search our directory for sleep clinics that specialize in treating hypoventilation syndromes.
Search Clinics